Yan Wei Selected Research

tanshinone

1/2021	'Adhesion and release' nanoparticle-mediated efficient inhibition of platelet activation disrupts endothelial barriers for enhanced drug delivery in tumors.
1/2018	Tanshinone IIA protects against polyethylene particle-induced osteolysis response in a mouse calvarial model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Wei Research Topics

Disease

43	Neoplasms (Cancer) 04/2022 - 01/2006
10	Infections 01/2021 - 06/2008
8	Cognitive Dysfunction 01/2021 - 04/2012
8	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 03/2011
7	Breast Neoplasms (Breast Cancer) 02/2021 - 10/2007
6	Wounds and Injuries (Trauma) 01/2022 - 09/2016
6	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 08/2009
6	Inflammation (Inflammations) 01/2021 - 09/2016
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
5	Carcinogenesis 04/2022 - 07/2017
5	Nasopharyngeal Carcinoma 04/2022 - 03/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2017
4	Thrombosis (Thrombus) 01/2021 - 03/2012
4	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2012
4	Reperfusion Injury 11/2018 - 01/2010
4	Asthma (Bronchial Asthma) 01/2018 - 01/2017
4	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 09/2011
3	Burns 11/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2018
3	Brain Ischemia (Cerebral Ischemia) 09/2021 - 01/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 09/2015
3	Body Weight (Weight, Body) 03/2021 - 11/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2021 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 08/2017
3	Stroke (Strokes) 01/2021 - 08/2019
3	Diabetes Mellitus 01/2021 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2018
3	Osteolysis 01/2019 - 01/2018
3	Respiratory Hypersensitivity 01/2018 - 01/2017
3	Dehydration (Water Stress) 10/2017 - 07/2015
3	Neuroblastoma 10/2015 - 08/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011 - 06/2009
3	Dengue (Dengue Fever) 04/2011 - 06/2008
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 02/2021
2	Treatment-Resistant Depressive Disorder 01/2022 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2018
2	Pathologic Processes 01/2022 - 12/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2019
2	Parkinson Disease (Parkinson's Disease) 12/2021 - 02/2010
2	Mouth Neoplasms (Oral Cancer) 05/2021 - 01/2021
2	Insulin Resistance 03/2021 - 01/2019
2	Obesity 03/2021 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2017
2	Hemorrhage 01/2021 - 10/2018
2	Distal Femoral Fractures 01/2021 - 06/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2008
14	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
13	Pharmaceutical PreparationsIBA 01/2022 - 09/2011
9	Peptides (Polypeptides)IBA 01/2021 - 09/2011
8	Ribose (D-Ribose)IBA 01/2022 - 08/2009
8	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 12/2013
5	HydrogelsIBA 11/2022 - 02/2020
5	EnzymesIBA 04/2022 - 06/2007
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2003
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2021 - 03/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2011
4	Advanced Glycation End ProductsIBA 01/2022 - 10/2015
4	PolymersIBA 01/2022 - 07/2010
4	CytokinesIBA 03/2021 - 12/2012
4	Formaldehyde (Formol)FDA Link 01/2021 - 04/2014
4	Liposomes (Liposome)IBA 11/2020 - 08/2017
4	Interleukin-17 (Interleukin 17)IBA 01/2018 - 11/2014
3	Glutamine (L-Glutamine)FDA Link 11/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
3	FructoseIBA 01/2022 - 05/2013
3	Oxygen (Dioxygen)IBA 06/2021 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2010
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2015
3	Long Noncoding RNAIBA 01/2018 - 01/2017
3	Chloride Channels (Chloride Channel)IBA 03/2016 - 03/2013
3	LigandsIBA 01/2015 - 11/2013
2	GelatinIBA 11/2022 - 01/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2022
2	Amino Acids FDA Link 01/2022 - 01/2019
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 03/2021
2	Drug CarriersIBA 01/2022 - 01/2011
2	Glycated Serum ProteinsIBA 01/2022 - 01/2019
2	EsketamineIBA 01/2022 - 01/2020
2	Nasal SpraysIBA 01/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 09/2021 - 08/2015
2	Biocompatible Materials (Biomaterials)IBA 05/2021 - 10/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021 - 08/2003
2	Docetaxel (Taxotere)FDA Link 02/2021 - 07/2010
2	Trastuzumab (Herceptin)FDA Link 02/2021 - 01/2020
2	poly(lactide) (polylactic acid)IBA 01/2021 - 01/2014
2	tanshinoneIBA 01/2021 - 01/2018
2	Epoxide HydrolasesIBA 01/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2018
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2020
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2019

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2003
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2006
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2019
3	Neoadjuvant Therapy 02/2021 - 10/2007
2	Stents 08/2021 - 07/2010
2	Catheters 01/2021 - 01/2020
2	Glycemic Control 01/2021 - 01/2019